Clinical Trial Update: Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the combination of radiation therapy with gadolinium texaphyrin for brain metastases and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Cancer

Drugs mentioned

• Gadolinium texaphyrin (motexafin gadolinium)

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Metastatic Cancer | Phase 3 | Status: COMPLETED